Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
about
Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.Accelerated ferumoxytol-enhanced 4D multiphase, steady-state imaging with contrast enhancement (MUSIC) cardiovascular MRI: validation in pediatric congenital heart disease.Positive contrast high-resolution 3D-cine imaging of the cardiovascular system in small animals using a UTE sequence and iron nanoparticles at 4.7, 7 and 9.4 T.Safety and technique of ferumoxytol administration for MRI.MR Angiography of Renal Transplant Vasculature with Ferumoxytol:: Comparison of High-Resolution Steady-State and First-Pass AcquisitionsVascular Imaging With Ferumoxytol as a Contrast Agent.Imaging of venous compression syndromes.Intravenous Ferumoxytol in Pediatric Patients With Iron Deficiency Anemia.Free-breathing pediatric chest MRI: Performance of self-navigated golden-angle ordered conical ultrashort echo time acquisition.Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.Gadolinium-based contrast agents in pediatric magnetic resonance imaging.Use of blood pool agents with steady-state MRI to assess the vascular system.Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.Acute effects of ferumoxytol on regulation of renal hemodynamics and oxygenation.Assessment of the precision and reproducibility of ventricular volume, function, and mass measurements with ferumoxytol-enhanced 4D flow MRI.Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits.Tracking short-term biodistribution and long-term clearance of SPIO tracers in magnetic particle imaging.Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.Current status of the treatment of infrarenal abdominal aortic aneurysms.
P2860
Q30234702-53A9FB14-7045-4F3D-A4A9-10B35506C85EQ30395371-67A03F6C-63C1-4C3C-99DC-2FD1BD70E29CQ30656936-AA5232F0-C2F9-48BC-8B00-F3D4A85B8772Q36862859-AECB16C7-EB32-436E-BB76-FDFA59C23514Q36867051-0B533B8A-EEB5-4832-B7A2-C5D4FE122018Q37458797-D025AE28-222C-4A30-BA48-F9F3B11EA6ECQ37570808-A75B30C1-E00D-4877-A1BC-2389A9BCF28DQ38722040-E0D4742C-8022-437D-A0B7-C2FC9E66BFD2Q38751156-AF0A72FD-CE46-4372-A587-10CFCCA08829Q38802402-B0DA2AFF-5D8A-435F-BEB9-9DE26033FCB4Q39242162-1C8B6800-E52F-4F0B-ACF5-0778E08F280BQ39250421-A4E767BC-378D-46B2-B351-E2E001E71297Q39439478-603F7067-94FE-4B79-85FB-F584C4D2D7D5Q41815227-01E96C5F-C13D-495F-A7EF-CCC2812A6436Q42185005-CBE41F66-F924-4CA4-848F-F41C47FDE4B2Q46071655-90EBB3B4-8F43-44FF-9139-2451461F0052Q46218436-5077C08D-2F49-4E2A-9E58-88FA58D61EAEQ47367815-B6E3049A-9CE6-4591-BEEB-8E3AA68F62DCQ55001960-D9D63D59-5537-4DD9-AB53-B2F10EED2363
P2860
Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Ferumoxytol as an off-label co ...... hy: a pilot study in children.
@ast
Ferumoxytol as an off-label co ...... hy: a pilot study in children.
@en
type
label
Ferumoxytol as an off-label co ...... hy: a pilot study in children.
@ast
Ferumoxytol as an off-label co ...... hy: a pilot study in children.
@en
prefLabel
Ferumoxytol as an off-label co ...... hy: a pilot study in children.
@ast
Ferumoxytol as an off-label co ...... hy: a pilot study in children.
@en
P2860
P1433
P1476
Ferumoxytol as an off-label co ...... hy: a pilot study in children.
@en
P2093
Albert Hsiao
Nichanan Ruangwattanapaisarn
P2860
P2888
P304
P356
10.1007/S00247-014-3226-3
P577
2014-11-27T00:00:00Z